Table 1.
Market prices, individual costs, coverage rates, and inequalities for childhood non-National Immunization Program vaccines in China, 2019
| Market price per dose ($)22, 23, 24, 25 | Total individual cost per child ($)* |
Vaccine coverage rate (95% CI)6 |
Vaccine coverage inequality (95% CI)6 |
|||
|---|---|---|---|---|---|---|
| One dose | Three doses | One dose | Three doses | |||
| PCV13 | 101·16 | 314·34 | 7·7% (6·9–8·4) | 5·1% (4·5–5·8) | 0·60 (0·57–0·64) | 0·64 (0·60–0·68) |
| Rotavirus vaccine† | 26·50 | 90·36 | 20·3% (19·2–21·3) | 1·8% (1·3–2·2) | 0·38 (0·36–0·41) | 0·77 (0·71–0·83) |
| Hib vaccine | 11·62 | 45·72 | 42·6% (41·3–44·0) | 25·0% (23·7–26·3) | 0·29 (0·28–0·31) | 0·43 (0·41–0·45) |
| Varicella vaccine‡ | 20·79 | 24·41 | 67·1% (65·4–68·8) | .. | 0·13 (0·12–0·15) | .. |
PCV13=13-valent pneumococcal conjugate vaccine. Hib=Haemophilus influenzae serotype b.
*
Individuals were charged an additional cost of CN¥25 ($3·62) per dose for an immunisation service fee for non-National Immunization Program vaccines.
†
The predominant rotavirus vaccine in 2019 was the lamb rotavirus vaccine, so its corresponding market price per dose for that year was used.
‡
One dose of varicella vaccine was often administered in China.